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Protocol
AbstrACt
Introduction Hypertensive disorders of pregnancy (HDPs), 
that is chronic hypertension, gestational hypertension, 
pre-eclampsia (de novo or superimposed on chronic 
hypertension) and white coat hypertension, affect 
approximately 5%–15% of pregnancies. HDP exposure 
has been linked to an increased risk of autism spectrum 
disorder, attention deficit/hyperactivity disorder and other 
neurodevelopmental disorders in children. However, 
findings are inconsistent, and a clear consensus on 
the impact of HDPs on the risk of neurodevelopmental 
disorders is needed. Therefore, we aim to synthesise the 
published literature on the relationship between HDPs and 
the risk of neurodevelopmental disorders in the form of a 
systematic review and meta-analysis.
Methods and analysis We will include cohort, case–
control and cross-sectional studies in which diagnosis of 
an HDP was reported, and neurodevelopmental disorders 
were the outcome of interest based on a preprepared 
protocol. A systematic search of PubMed, CINAHL, Embase, 
PsycINFO and Web of Science will be conducted in 
accordance with a detailed search strategy. Two authors 
will independently review the titles and abstracts of all 
studies, perform data extraction using a standardised 
data collection form and assess study quality using a 
bias classification tool. Meta-analyses will be performed 
to calculate overall pooled estimates using the generic 
inverse variance method. This systematic review will be 
reported according to the Preferred Reporting Items for 
Systematic reviews and Meta-Analyses.
Ethics and dissemination This proposed systematic 
review and meta-analysis is based on published data, 
therefore, does not require ethics approval. Findings will 
be presented at scientific conferences and disseminated 
through publication in a peer-reviewed journal.
registration CRD42017068258.
IntroduCtIon
Hypertensive disorders of pregnancy (HDPs) 
are the most common complications of preg-
nancy estimated to affect approximately 
5%–15% of all pregnancies.1 2 HDPs are clas-
sified into four categories, as recommended 
by the International Society for the Study 
of Hypertension in Pregnancy3: ‘chronic 
hypertension’, ‘gestational hypertension’, 
‘pre-eclampsia—de novo or superimposed on 
chronic hypertension’ and ‘white coat hyper-
tension’. While HDPs are not fully under-
stood, risk factors include advanced maternal 
age and elevated body mass index, both of 
which are increasingly common in modern 
society.4 HDP create a hostile in utero envi-
ronment as a result of multiple pathophysio-
logical changes including reduced placental 
blood flow, maternal inflammation and 
oxidative stress.5 These can potentially alter 
fetal developmental trajectories, which 
may increase the risk of long-term vascular, 
cognitive and psychiatric sequelae in the 
offspring.4 6–8
Neurodevelopmental disorders including 
autism spectrum disorder (ASD) and atten-
tion deficit/hyperactivity disorder (ADHD) 
are a group of conditions with onset during 
the developmental period and may lead to 
impairments in personal, social, academic 
or occupational functioning.9 10 Though 
strengths and limitations of this study
 ► The proposed systematic review and meta-analysis 
will adhere to the Preferred Reporting Items for 
Systematic Reviews and Meta Analyses guidelines, 
ensuring consistency and uniformity in reporting the 
full systematic review.
 ► The review aims to provide a clear consensus on 
the relationship between hypertensive disorders of 
pregnancy and neurodevelopmental disorders in the 
offspring.
 ► Two reviewers will screen for study eligibility and 
perform the quality assessment, minimising the 
likelihood of reviewer-based bias in the systematic 
review.
 ► A limitation of the review is that it will only include 
the published literature in the English language.
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these disorders have a strong genetic basis,11 12 there is 
increasing evidence suggesting that environmental risk 
factors during prenatal development may also play a 
role.11 13–18 In support of this, a population-based study 
conducted on a Swedish population estimated that genes 
and environmental exposure each contribute approxi-
mately half of the overall risk of ASD, with this 50/50 
contribution remaining consistent across the study’s 
24-year span.11 Furthermore, recent work demonstrated 
focal patches of abnormal laminar architecture and 
laminar disorganisation in the prefrontal and temporal 
cortices of children with ASD suggesting there may be 
alterations in brain development at prenatal stages, 
as cortical lamination is ongoing during the second 
trimester of pregnancy.19 20 Moreover, there is some 
evidence for alterations in brain structural and vascular 
anatomy21 and reduced cognitive functioning22 in 
offspring of pregnancies complicated by pre-eclampsia 
pregnancies. There is therefore a need to determine the 
impact of HDP exposure on the risk of adverse neurode-
velopmental outcomes in the children.
Early identification and intervention
There is a growing consensus that early identification 
and intervention are key to improving long-term neuro-
developmental outcomes.23 24 Previously published work 
has indicated that early behavioural intervention if 
commenced before 30 months old, can lead to improve-
ments in cognitive and adaptive behaviour among 
individuals with ASD.25 26 Despite this increasing recog-
nition for surveillance, the average age of ASD diagnosis 
remains at approximately 4–5 years, meaning the window 
for intervention has closed.23 27 28 However, research 
suggests that a stable diagnosis can be made as young as 
2 years, allowing earlier access to specialised services.29 
Therefore, by examining the potential impact of HDP on 
neurodevelopment in offspring, it can inform the need 
for increased paediatric surveillance of infants who have 
been exposed to HDP. This in turn could allow for early 
intervention that may aid improvement of neurodevelop-
mental outcome.23 25 26 30
rationale for current systematic review
Evidence suggests that HDP may lead to an increased 
risk of ASD, ADHD as well as other neurodevelopmental 
disorders in children.15 31 32 Conversely, other studies 
have reported no association,13 31 highlighting the need 
for further study in this area. Therefore, the aim of this 
systematic review and meta-analysis is to summarise the 
available evidence examining the association between 
pre-eclampsia and gestational hypertension, and subse-
quent risk of neurodevelopmental disorders in exposed 
children, and if possible to identify an overall pooled esti-
mate of association. The systematic review will be based 
on the following requirements:
Population
Pregnant women and their children.
Intervention/exposures
HDP.
Primary exposure: pre-eclampsia.
Secondary exposure: other HDP.
Comparison
No diagnosis of HDP.
outcomes
Primary outcome 1: ASD.
Primary outcome 2: ADHD.
Secondary outcomes: other neurodevelopmental disorders.
MEthods And dEsIgn
This systematic review and meta-analysis will follow the 
Preferred Reporting Items for Systematic Reviews and 
Meta Analyses (PRISMA) guidelines.33
objECtIvEs
This study aims to conduct a systematic review and 
meta-analysis to examine the association between HDP 
and neurodevelopmental disorders in the offspring.
rEvIEw quEstIon
This systematic review will address the following research 
question:
What are the pooled estimates from existing literature 
examining the association between HDP and neurodevel-
opmental disorders in the offspring?
CrItErIA for ConsIdErIng studIEs for thE rEvIEw
Inclusion criteria
 ► We will include cohort, case–control or cross-sectional 
studies in which a diagnosis of HDP was reported and 
neurodevelopmental disorders are the outcome of 
interest.
 ► Examining the association between HDP and 
neurodevelopmental disorders must be part of the 
main objective of the study. (This includes studies that 
aimed to look at other perinatal risk factors in addi-
tion to HDP.)
 ► Data must be from an original study, and HDP may 
be confirmed through medical records or doctor-di-
agnosed self-reporting.
 ► We will include studies published in English only, 
including all years from inception of the electronic 
databases until June 2017.
 ► Peer-reviewed literature only will be included.
 ► Neurodevelopmental and other behavioural or cogni-
tive outcomes will be the focus of this review. Motor 
disorders have been included in the search strategy 
to capture studies that have included these outcomes.
Exclusion criteria
 ► Studies that are not in English.
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 ► Studies where the participants are not human.
 ► Case reports, case series, letters, commentaries, notes, 
editorials and conference abstracts.
search strategy for identifying relevant studies
Bibliographic database searches
1. One reviewer (GMM) will conduct a systematic search 
of the literature in the following electronic databases: 
PubMed, CINAHL, Embase, PsycINFO and Web of 
Science. A detailed search strategy has been compiled, 
and these terms will be searched according to the 
principles of Boolean Logic (AND, OR and NOT) 
and using Medical Subject Headings. For example, 
(‘Pre-eclampsia’ OR ‘gestational hypertension’) AND 
(‘autism spectrum disorder’ OR ‘attention deficit/
hyperactivity disorder’ OR ‘neurodevelopmental 
disorder’). (The full search strategy is included in 
online supplementary file 1).
2. Searches of the electronic databases will be 
supplemented by hand-searching the reference lists 
of included studies for further potentially eligible 
studies.
Selection of studies for inclusion in the review
Titles and abstracts of studies retrieved from each data-
base search will be stored and managed in EndNote refer-
ence manager. Two review authors (GMM and ASK) will 
independently review the titles and abstracts of all studies. 
Full texts will be obtained where necessary to screen 
for eligibility in the systematic review and meta-analysis 
in accordance with the predefined inclusion/exclu-
sion criteria. Where consensus on eligibility cannot be 
achieved, a third review author (GWOK) will be involved 
in the discussion.
Data extraction and management
Using a standardised data collection form, two reviewers 
(GMM and GWOK) will independently extract data 
from the eligible studies including the author and year 
of publication, study design, definition of exposure and 
outcome used, sample size, confounders adjusted for (if 
any) as well as crude and adjusted estimates. Discrepan-
cies will be resolved by a third reviewer (ASK) if necessary.
Appraisal of the quality of included studies
Quality assessment of the included studies will be 
conducted by two reviewers (GMM and PMK) inde-
pendently and agreed on subsequently using an appro-
priate quality assessment tool depending on the study 
design. Discrepancies will be resolved by a third reviewer 
(ASK) if necessary. A bias classification tool described 
in detail elsewhere will be used.34 In summary, this tool 
uses a checklist to assess common features of the six types 
of bias most often associated with observational studies 
(selection, exposure, outcome, analytic, attrition and 
confounding). Study bias is then classified as minimal, 
low, moderate, high or not reported for each of the six 
types of bias and an overall likelihood of bias based on 
the total of the six types of bias will be measured and 
reported. For example, selection bias will be minimised 
if the sample was taken from a ‘consecutive unselected 
population’, while conversely a study with high selection 
bias will arise if sample selection is ambiguous and the 
sample is not likely representative.
Data synthesis including assessment of heterogeneity
Where the data allow, meta-analyses will be performed 
to calculate overall pooled estimates of the relationship 
between combined HDP, pre-eclampsia and gestational 
hypertension, and different disorders of neurodevelop-
ment. Both crude and adjusted results will be displayed 
where possible using the generic inverse variance method. 
Adjustment will be based on the definition outlined in 
each identified study and a hierarchy of adjustment 
created depending on the factors that are adjusted for. 
Studies that report similar adjustments will be analysed 
separately in crude and adjusted models to assess poten-
tial confounding among studies that reported adjusted 
estimates.
A fixed-effects model will be used where heterogeneity 
is low (I2 value of less than 50%), and a random-effects 
model where heterogeneity is high (I2 value of 50% or 
more) according to the Cochrane Handbook criteria.35
We will also perform the following subgroup/sensitivity 
analyses where the data allow, using RevMan 5.3:
1. according to study design (cohort vs case–control vs 
cross-sectional)
2. according to studies that report estimates for the asso-
ciation between pre-eclampsia and gestational hyper-
tension and each neurodevelopmental disorder
3. according to location (eg, Europe vs USA)
4. according to income level of country (low/middle/
high)
5. according to study quality (minimal/low vs moder-
ate/high)
6. according to measurement of exposure and outcome 
data (self-reported vs medical records based on 
varying clinical coding systems).
Publication bias will be assessed using a funnel plot 
provided at least 10 or more studies are included in the 
meta-analysis. The trim and fill method will also be used 
to identify and correct for funnel plot asymmetry arising 
from publication bias.36 Where any other subgroup/
sensitivity analyses are identified in the process of the 
meta-analysis, such as analyses to explore potential high 
heterogeneity or publication bias, these will be clearly 
labelled as post hoc analyses.
Presenting and reporting the results
A flow diagram (as outlined in the PRISMA statement33) 
will be included to outline the study selection process 
step by step, and a rationale provided for excluded 
studies. The characteristics and quality assessment of the 
included studies will be presented in tables. Pooled esti-
mates will be presented using forest plots. Where a study 
is eligible for inclusion in the systematic review but does 
not provide adequate data to include in a meta-analysis, 
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we will contact the corresponding authors in an attempt 
to obtain raw data where appropriate. If raw data cannot 
be obtained, the findings will be included individually in 
a separate table.
ConClusIon
This systematic review and meta-analysis will summarise 
existing literature examining the association between 
HDP and different disorders of neurodevelopment based 
on a preprepared protocol. By identifying the possible 
contributors to adverse neurodevelopmental outcomes, it 
may lead to early identification and intervention. There-
fore, by examining potential aetiologies of neurodevel-
opmental disorders, it may inform the need for greater 
paediatric surveillance of HDP-exposed infants to allow 
early intervention, which may aid improvement of neuro-
developmental outcome.23 25 26 30
Potential limitations
It is anticipated that publication bias may pose as a limita-
tion for this review. Studies that show an effect have an 
increased likelihood of being published as well as being 
published in English. Due to limited resources, the system-
atic review search will be confined to studies published in 
the English language only, potentially resulting in publi-
cation bias as well as relevant indexed studies being over-
looked. If possible, a funnel plot will be used to assess the 
presence of publication bias.
Furthermore, the presence of confounding is a major 
concern in observational studies. Potential confounders 
may include infant sex, family’s socioeconomic status, 
ethnicity, maternal age, parity, maternal smoking and 
alcohol status during pregnancy, maternal use of antide-
pressants (during pregnancy or during the preconcep-
tion period) and maternal mental illness, while preterm 
delivery and small for gestational age could potentially 
play a confounding or mediating role. As mentioned 
above, our meta-analyses will display both crude and 
adjusted results where possible using the generic inverse 
variance method, basing adjustment on the definition 
outlined in each identified study.
Ethics and dissemination
Given that this is a protocol for a systematic review and 
based on published data, there is no requirement for 
ethics approval. It is anticipated that dissemination of 
results will take place at conferences and through publi-
cation in a peer-reviewed journal.
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